Israeli Protalix Partners With Germany’s Secarna on Rare Kidney Disease…
Israeli Protalix BioTherapeutics partners with Germany’s Secarna Pharmaceuticals to develop rare kidney disease therapies, leveraging…
Read More



















Israeli Protalix BioTherapeutics partners with Germany’s Secarna Pharmaceuticals to develop rare kidney disease therapies, leveraging…
Read MoreIsraeli ICL agrees to acquire Canada’s Bartek Ingredients for $90 million in a two-phase deal…
Read MoreIsraeli-US focused ultrasound company Insightec spins out Lotus Neuro, a new biotech firm to speed…
Read MoreIsrael greenlights a historic $35 billion natural gas export agreement with Egypt, its largest energy…
Read MoreGerman lawmakers approved a $3.1 billion expansion for the Arrow 3 missile defense system, making…
Read MoreIsraeli authorities arrested two suspects in northern Israel recently for planning to travel abroad for…
Read MoreIsrael anticipates 130,000 visitors, including 40,000 Christian pilgrims, for robust post-war Christmas tourism this December.…
Read MoreIsraeli scientists from Hebrew University unveiled a new gene-editing method today, December 17, to easily…
Read MoreA new study, co-led by Israeli researchers, warns nearly 8,000 animal species face extinction this…
Read MoreNorwegian carrier Gram Car Carriers adopts Israeli Orca AI's fleet-wide maritime safety platform for its…
Read More